【ChiCTR2300068085】A brief mindfulness intervention based on mobile apps to reduce anxiety and stress for Indonesian senior high school teachers: A Pilot Randomized Controlled Trial
ChiCTR2300068085
尚未开始
/
/
/
2023-02-06
/
/
Mental health
A brief mindfulness intervention based on mobile apps to reduce anxiety and stress for Indonesian senior high school teachers: A Pilot Randomized Controlled Trial
A brief mindfulness intervention based on mobile apps to reduce anxiety and stress for Indonesian senior high school teachers: A Pilot Randomized Controlled Trial
81116
The main objective of this pilot study is to evaluate the potential of the brief mindfulness based on mobile apps implementation in real-world settings. The secondary objectives are to determine the effectiveness of the brief-mindfulness intervention based on mobile apps (BM-MA) in reducing participant-reported anxiety symptoms; to evaluate the effectiveness of the BM-MA in reducing participant-reported stress symptoms and improving life satisfaction, self-compassion and sense of self-efficacy; and to evaluate the BM-MA potential for implementation in real-world settings.
随机平行对照
其它
Participants will be randomized by the built-in algorithm in the mobile app with 1:1 ratio to the treatment (BM-MA) and control group. The algorithm is designed for permuted block randomization where the total number of participants is set prior to the randomization.
无
Universitas Pendidikan Ganesha, Indonesia
/
290;289
/
2023-02-01
2023-12-31
/
1. Indonesian-certified senior high school teachers who are able to read and write in Indonesian; 2. Adults who are above 18 years of age; 3. Have access to smartphone use; 4. The total GAD-7 score is no more than 14 and the total GHQ-12 score is no more than 20.;
请登录查看The exclusion criteria for randomized controlled trial are set based on guidelines from MBSR (Santorelli, 2014) and MBCT (Crane et al., 2012), and include 1. Engagement with regular practice of mindfulness meditation [e.g for 15-20 mins a day, 2-3 times a week; 2. A history of, presence, or ongoing treatment for a psychological disorder; 3. A positive answer to GHQ-12 questions regarding suicidal; 4. Refusal to fill in the informed consent.;
请登录查看Universitas Pendidikan Ganesha, Indonesia
81116
Universitas Pendidikan Ganesha, Indonesia的其他临床试验
Universitas Pendidikan Ganesha, Indonesia的其他临床试验
最新临床资讯
-
大鹏制药临床III期成功
新药说2026-08-13
-
新一代 EGFR-TKI 首个全球 III 期成功
丁香园 Insight 数据库2026-08-13
-
体外诊断原料网2026-08-13
-
佰傲谷BioValley2026-08-13
-
久有基金2026-08-13
-
重庆宸安生物2026-08-13
-
UmabsDB2026-08-13
-
希格生科2026-08-13
-
bioSeedin柏思荟2026-08-13
-
智飞智讯2026-08-13
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-08-14
-
2026-08-14
-
2026-08-14
-
摩熵咨询 20 8
-
摩熵咨询 34 28
-
摩熵咨询 20 5
-
颁布机构:四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构:国家医保局 2026-07-31
-
颁布机构:国家药品审评中心(CDE) 2026-07-24
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-08-14
-
2026-08-13
-
2026-08-13
-
摩熵咨询 35 36
-
摩熵咨询 28 39
-
摩熵咨询 34 18
-
颁布机构:国家市场监督管理总局 2026-08-10
-
颁布机构:国家市场监督管理总局 2026-05-29
-
颁布机构:国家市场监督管理总局 2026-05-29
